Aptamers Targeting a Subunit or a Conformation of Glutamate Ion Channel Receptors

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  2013-07-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1201/B15152-38
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• MicroRNA conjugated gold nanoparticles and cell transfection.

  2012cited by this paper
• Natural products as sources of new drugs over the 30 years from 1981 to 2010.

  2012cited by this paper
• Antidote control of aptamer therapeutics: the road to a safer class of drug agents.

  2012cited by this paper
• Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers.

  2012cited by this paper
• Functional relevance of miRNA sequences in human disease.

  2012cited by this paper
• Magnetic silica spheres with large nanopores for nucleic acid adsorption and cellular uptake.

  2012cited by this paper
• Branched, Tripartite-Interfering RNAs Silence Multiple Target Genes with Long Guide Strands

  2012cited by this paper
• miRNA-Mediated Gene Silencing by Translational Repression Followed by mRNA Deadenylation and Decay

  2012cited by this paper
• Mechanism of Inhibition of the GluA2 AMPA Receptor Channel Opening by 2,3-Benzodiazepine Derivatives: Functional Consequences of Replacing 7,8-Methylenedioxy with 7,8-Ethylenedioxy Moiety

  2012cited by this paper
• The microRNAs, MiR‐31 and MiR‐375, as candidate markers in Barrett's esophageal carcinogenesis

  2012cited by this paper
• RNA-based therapeutics: current progress and future prospects.

  2012cited by this paper
• EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers

  2011cited by this paper
• Organic synthesis toward small-molecule probes and drugs

  2011cited by this paper
• Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis

  2011cited by this paper
• GluA4 is indispensable for driving fast neurotransmission across a high‐fidelity central synapse

  2011cited by this paper
• Mechanism of inhibition of the GluA2 AMPA receptor channel opening: consequences of adding an N-3 methylcarbamoyl group to the diazepine ring of 2,3-benzodiazepine derivatives.

  2011cited by this paper
• Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides

  2011cited by this paper
• An HNF4a-miRNA Inflammatory Feedback Circuit Regulates Hepatocellular Oncogenesis

  2011cited by this paper
• Fabrication of stable and RNase-resistant RNA nanoparticles active in gearing the nanomotors for viral DNA packaging.

  2011cited by this paper
• Mechanism of Inhibition of the GluA2 AMPA Receptor Channel Opening: the Role of 4-Methyl versus 4-Carbonyl Group on the Diazepine Ring of 2,3-Benzodiazepine Derivatives.

  2011cited by this paper
• Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease.

  2011cited by this paper
• Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery.

  2011cited by this paper
• Targeted Delivery of Mutant Tolerant Anti-Coxsackievirus Artificial MicroRNAs Using Folate Conjugated Bacteriophage Phi29 pRNA

  2011cited by this paper
• MicroRNA-24 Regulates Vascularity After Myocardial Infarction

  2011cited by this paper
• Hippocampal Lesions can Enhance Discrimination Learning Despite Normal Sensitivity to Interference From Incidental Information

  2011cited by this paper
• Thermodynamically Stable RNA three-way junctions as platform for constructing multi-functional nanoparticles for delivery of therapeutics

  2011cited by this paper
• Potent and Selective Inhibition of a Single α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Subunit by an RNA Aptamer*

  2011cited by this paper
• MicroRNA-101 Regulates Amyloid Precursor Protein Expression in Hippocampal Neurons*

  2010cited by this paper
• The AMPA receptor as a therapeutic target: current perspectives and emerging possibilities.

  2010cited by this paper
• Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance

  2010cited by this paper
• The emerging field of RNA nanotechnology.

  2010cited by this paper
• A Multidimensional Strategy to Detect Polypharmacological Targets in the Absence of Structural and Sequence Homology

  2010cited by this paper
• Glutamate Receptor Ion Channels: Structure, Regulation, and Function

  2010cited by this paper
• The role of habituation in hippocampus-dependent spatial working memory tasks: Evidence from GluA1 AMPA receptor subunit knockout mice

  2010cited by this paper
• MicroRNA-328 Contributes to Adverse Electrical Remodeling in Atrial Fibrillation

  2010cited by this paper
• The promise of microRNA replacement therapy.

  2010cited by this paper
• OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma

  2010cited by this paper
• Co-delivery of as-miR-21 and 5-FU by Poly(amidoamine) Dendrimer Attenuates Human Glioma Cell Growth in Vitro

  2010cited by this paper
• Mammalian microRNAs: experimental evaluation of novel and previously annotated genes.

  2010cited by this paper
• Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells

  2010cited by this paper
• Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.

  2010cited by this paper
• Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21.

  2010cited by this paper
• Pharmaceutical Technologies for Enhancing Oral Bioavailability of Poorly Soluble Drugs

  2010cited by this paper
• Potent and selective inhibition of the open-channel conformation of AMPA receptors by an RNA aptamer.

  2010cited by this paper
• Current hypotheses for the underlying biology of amyotrophic lateral sclerosis

  2009cited by this paper
• Crystal structure of the ATP-gated P2X4 ion channel in the closed state

  2009cited by this paper
• X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor

  2009cited by this paper
• A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.

  2009cited by this paper
• MicroRNA-320 Is Involved in the Regulation of Cardiac Ischemia/Reperfusion Injury by Targeting Heat-Shock Protein 20

  2009cited by this paper
• MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice

  2009cited by this paper
• Roles of the AMPA receptor subunit GluA1 but not GluA2 in synaptic potentiation and activation of ERK in the anterior cingulate cortex

  2009cited by this paper
• Robotic multiwell planar patch-clamp for native and primary mammalian cells

  2009cited by this paper
• Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells.

  2009cited by this paper
• Flip and flop: a molecular determinant for AMPA receptor channel opening.

  2009cited by this paper
• Targeting AMPA and kainate receptors in neurological disease: therapies on the horizon?

  2009cited by this paper
• High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-β1

  2009cited by this paper
• Structure of the S1S2 glutamate binding domain of GLuR3

  2009cited by this paper
• A nomenclature for ligand-gated ion channels.

  2009cited by this paper
• Mechanisms of antagonism of the GluR2 AMPA receptor: structure and dynamics of the complex of two willardiine antagonists with the glutamate binding domain.

  2009cited by this paper
• miR-21 plays a pivotal role in gastric cancer pathogenesis and progression

  2008cited by this paper
• Deadenylation is a widespread effect of miRNA regulation.

  2008cited by this paper
• The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease

  2008cited by this paper
• Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR.

  2008cited by this paper
• MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer

  2008cited by this paper
• MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators

  2008cited by this paper
• Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression

  2008cited by this paper
• Natural products in drug discovery.

  2008cited by this paper
• MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

  2008cited by this paper
• Synaptic AMPA receptor subunit trafficking is independent of the C terminus in the GluR2-lacking mouse

  2008cited by this paper
• Endocytosis and recycling of AMPA receptors lacking GluR2/3

  2008cited by this paper
• Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.

  2008cited by this paper
• Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

  2008cited by this paper
• The substrates of memory: defects, treatments, and enhancement.

  2008cited by this paper
• Annotation of tertiary interactions in RNA structures reveals variations and correlations.

  2008cited by this paper
• Mechanism of inhibition of the GluR2 AMPA receptor channel opening by 2,3-benzodiazepine derivatives.

  2008cited by this paper
• Structural Elements in RNA

  2008cited by this paper
• The State of Innovation in Drug Development

  2008cited by this paper
• A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons

  2007cited by this paper
• Gene therapy progress and prospects: RNA aptamers

  2007cited by this paper
• RNA aptamers selected against the GluR2 glutamate receptor channel.

  2007cited by this paper
• Immobilized P2X2 purinergic receptor stationary phase for chromatographic determination of pharmacological properties and drug screening.

  2007cited by this paper
• MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure

  2007cited by this paper
• When poor solubility becomes an issue: from early stage to proof of concept.

  2007cited by this paper
• MicroRNA-133 controls cardiac hypertrophy

  2007cited by this paper
• GluR3 flip and flop: differences in channel opening kinetics.

  2007cited by this paper
• MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.

  2007cited by this paper
• Water soluble RNA based antagonist of AMPA receptors.

  2007cited by this paper
• mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes.

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond

  2006cited by this paper
• Crystal Structures of the Kainate Receptor GluR5 Ligand Binding Core Dimer with Novel GluR5-Selective Antagonists

  2006cited by this paper
• Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptor‐mediated excitotoxicity in ALS

  2006cited by this paper
• Refined structure of the nicotinic acetylcholine receptor at 4A resolution.

  2005cited by this paper
• In vitro RNA random pools are not structurally diverse: a computational analysis.

  2005cited by this paper
• The Molecular Pharmacology and Cell Biology of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors

  2005cited by this paper
• MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies

  2005cited by this paper
• Enhancing protein expression in single HEK 293 cells.

  2005cited by this paper
• Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation.

  2005cited by this paper
• New NTP analogs: the synthesis of 4′-thioUTP and 4′-thioCTP and their utility for SELEX

  2005cited by this paper
• AMPA receptor antagonists for the treatment of stroke.

  2005cited by this paper

• No citing papers are available for this paper.